well, we got EU approval of dacogen in elderly AML, then we get an announcement of a new Phase 2 trial underway, and the stock is: DOWN? (i should have been a market maker)
this makes almost no sense to me. maybe the pre-AML announcement run up sapped all our juice
In over a decade Manuso has taken the money but has not shown any results.
Unless and Until the company has a proven marketable compound for sale instead of relying on a “retread” of an existing drug, nada!
How this guy could year after year take the money but delivery nothing ??????
Don't sweat it East. If you were trading this daily, weekly etc then you may have an issue. If you are L/T on this stock then it may be a winner. I own this stock because of the multiple irons in the fire and the cash in the bank and royalties that backstop the stock. I think that eventually someone will see the value in this company and buy it.